🚀
Enjoy a 7-Day Free Trial Thru Apr 27, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Drug Manufacturers
CV Sciences Inc (OTCPK:CVSI)
News
CV Sciences Inc
OTCPK
:CVSI (USA) Â
$ 0.04
+0.00298 (+8.09%)
10:08 PM EST
P/E:
2.34
P/B:
1.99
Market Cap:
$ 6.50M
Enterprise V:
$ 5.13M
Volume:
87.27K
Avg Vol (2M):
269.30K
Warning! GuruFocus detected 3 Severe warning signs with CVSI.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
87.27K
Market Cap $:
6.50M
PE Ratio:
2.34
Avg Vol (2M):
269.30K
Enterprise Value $:
5.13M
PB Ratio:
1.99
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocks™
Compare
0
Summary
30-Y Financials
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
CV Sciences Inc (OTCPK:CVSI) Stock News, Headlines & Updates
CV Sciences Inc Stock News from GuruFocus
Total 166
1
2
3
4
5
Mar 29, 2024
Q4 2023 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
11:04pm
Mar 26, 2024
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
PRNewswire
•
8:00am
Mar 21, 2024
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
PRNewswire
•
9:00am
Feb 13, 2024
Q3 2023 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
Q2 2023 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
CV Sciences Inc at LD Micro Invitational Conference Transcript
GuruFocus Research
•
12:31am
Q1 2023 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
Q4 2022 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
Q3 2022 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
Q2 2022 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
CV Sciences Inc Annual Shareholders Meeting Transcript
GuruFocus Research
•
12:31am
Q1 2022 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
Q4 2021 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:31am
Q3 2021 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Q2 2021 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Q1 2021 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Q4 2020 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Q2 2020 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Q4 2019 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Q1 2019 CV Sciences Inc Earnings Call Transcript
GuruFocus Research
•
12:30am
Dec 12, 2023
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
PRNewswire
•
8:00am
Nov 14, 2023
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
PRNewswire
•
12:03am
Sep 05, 2023
CV Sciences, Inc. Launches Reserve Sleep Gummies
PRNewswire
•
8:00am
Aug 14, 2023
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
PRNewswire
•
9:00am
Aug 01, 2023
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
PRNewswire
•
9:00am
Jun 11, 2022
CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022
GuruFocusNews
•
7:05am
May 12, 2022
CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022
GuruFocusNews
•
6:19am
Mar 28, 2022
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022
GuruFocusNews
•
4:01pm
Mar 11, 2022
UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
GuruFocusNews
•
12:00pm
Mar 08, 2022
CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
GuruFocusNews
•
9:00am
Jan 05, 2022
CV Sciences, Inc. Announces New Distribution Agreement with GNC
GuruFocusNews
•
7:00am
Nov 30, 2021
CV Sciences, Inc. Appoints Haskell & White LLP as Auditor
GuruFocusNews
•
4:00pm
Nov 08, 2021
CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021
Don Li2
•
8:01am
Mar 10, 2021
CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
Marketwired
•
7:01am
Jan 05, 2021
CV Sciences, Inc. Announces Launch of ProCBD™ Product Line
Marketwired
•
11:01am
Dec 10, 2020
CV Sciences, Inc. Receives Nutritional Outlook's 2020 Best of the Industry Award
Marketwired
•
11:00am
Dec 08, 2020
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
Marketwired
•
7:00am
Nov 04, 2020
CV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line
Marketwired
•
7:00am
Oct 23, 2020
CV Sciences, Inc. to Announce Third Quarter 2020 Results on November 5, 2020
Marketwired
•
7:00am
Oct 06, 2020
CV Sciences, Inc. Announces PlusCBD™ Brand Refresh and New Product Launches
Marketwired
•
7:00am
Total 166
1
2
3
4
5
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news